[1] Kahn B B,Flier J S.Obesity and insulin resistance[J].J Clin Invest,2000,106(4):473-481. [2] Jung U J,Choi M S.Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease[J].Int J Mol Sci,2014,15(4):6184-6223. [3] Fukuhara A, Matsuda M, Nishizawa M, et al.Visfatin: a protein secreted by visceral fat that mimics the effects of insulin[J].Science,2005,307(5708):426-430. [4] Samal B, Sun Y, Stearns G,et al .Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor[J].Mol Cell Biol,1994,14(2):1431-1437. [5] Wang T,Zhang X,Bheda P,et al.Structure of Nampt/PBEF/visfatin,a mammalian NAD+ biosynthetic enzyme[J].Nat Struct Mol Biol,2006,13(7):661-662. [6] Jia S H,Li Y,Parodo J,et al.Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis[J].J Clin Invest,2004,113(9):1318-1327. [7] Kralisch S, Klein J, Lossner U, et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes[J]. J Endocrinol,2005,185(3):R1-R8. [8] Mayi T H, Duhem C, Copin C, et al. Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages[J].FASEB J,2010,277(16):3308-3320. [9] Asadi S,Goodarzi M T,Saidijam M,et al.Resveratrol attenuates visfatin and vaspin genes expression in adipose tissue of rats with type 2 diabetes[J].Iran J Basic Med Sci,2015,18(6):537-543. [10] Xie H,Tang S Y,Luo X H,et al.Insulin-like effects of visfatin on human Osteoblasts[J].Calcif Tissue Int,2007,80(3):201-210. [11] Revollo J R, Krner A, Mills K F, et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme[J]. Cell Metab,2007,6(5):363-375. [12] Moschen A R,Kaser A,Enrich B,et al.Visfatin,an adipocytokine with proinflammatory and immunomodulating properties[J].J Immunol,2007,178(3):1748-1758. [13] Kolsgaard M L, Wangensteen T, Brunborg C, et al. Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome[J]. Scand J Clin Laborat Invest,2009,69(8):858-864. [14] Catalán V,Gómez-Ambrosi J,Rodríguez A,et al.Association of increased visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity[J].Nutr Metab Cardiovasc Dis,2011,21(4):245-253. [15] Takesen D,Kirel B,Us T.Serum visfatin levels, adiposity and glucose metabolism in obese adolescents[J].J Clin Res Pediatr Endocrinol,2012,4(2):76-81. [16] Jian W X, Luo T H, Gu Y Y, et al. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population[J]. Diabet Med,2006,23(9):967-973. [17] Li R Z,Ma X,Hu X F,et al.Elevated visfatin levels in obese children are related to proinflammatory factors[J].J Pediatr Endocrinol Metab,2013,26(1-2):111-118. [18] Berndt J, Klo¨ting N, Kralisch S, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans[J].Diabetes,2005,54(10):2911-2916. [19] Pagano C, Pilon C, Olivieri M, et al. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans[J]. J Clin Endocrinol Metab,2006,91(8):3165-3170 [20] Chen M P, Chung F M, Chang D M, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus[J]. J Clin Endocrinol Meta,2006,91(1):295-299. [21] El-Mesallamy H O, Kassem D H, El-Demerdash E,et al.Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus[J]. Metab Clin Exp,2011,60(1):63-70. [22] Uslu S, Kebapci N, Kara M, et al. Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus[J]. Exp Thr Med, 2012, 4(1): 113-120. [23] Ahmed M B,Ismail M I,Meki A R.Relation of osteoprotegerin,visfatin and ghrelin to metabolic syndrome in type 2 diabetic patients[J].Int J Health Sci,2015,9(2): 127-139. [24] Lee S S,Kang S.Effects of regular exercise on obesity and type 2 diabete mellitus in Korean children: improvements glycemic control and serum adipokines level[J].J Phys Ther Sci,2015,27(6): 1903-1907. [25] 杨 媚,杨刚毅,李 伶,等.不同糖耐量个体血浆内脂素水平的变化[J].中华内分泌代谢杂志,2006,22(3):245-247. [26] Nourbakhsh M, Nourbakhsh M, Gholinejad Z,et al.Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome[J].Scand J Clin Lab Invest,2015,75(2):183-188. [27] Dogru T,Sonmez A,Tasci I,et al.Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance[J].Diabetes Res Clin Pract,2007,76(1):24-29.
PDF(512 KB)
